Ads
related to: new copd treatments
Search results
Plant-based diet may reduce risk of emphysema among smokers
United Press International via Yahoo News· 5 days agoThe findings, published recently in Chronic Obstructive Pulmonary Diseases: Journal of the COPD...
AMGEN HIGHLIGHTS NEW COPD, ASTHMA AND VASCULITIS RESEARCH AT ATS 2024
WFRV 5 Green Bay· 3 days agoAmgen (NASDAQ:AMGN) today announced the presentation of new respiratory data at the American Thoracic Society (ATS) 2024 International Conference...May 12-22 in San Diego.
Earnings call: Regeneron reports steady growth, prepares for new launches By Investing.com
Investing.com· 2 days agoThis growth was primarily driven by strong sales of Dupixent and Libtayo, as well as collaboration...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 3 days agoPDUFA Target Action Date of June 26, 2024 Eight posters including two oral presentations support potential of ensifentrine,an investigational, first-in-class, selective, dual inhibitor of PDE3 and PDE4 LONDON and RALEIGH, N.C., May 02, 2024
Regeneron Pharmaceuticals Inc (REGN) Q1 2024 Earnings Call Transcript Highlights: Key Financial ...
GuruFocus.com via Yahoo Finance· 2 days agoYou're right. From our perspective, we think the data broadly supports the entire BLA and as well as all these analyses, the approval of the drug in eosinophilic COPD. As ...
Regeneron Reverses On Better-Than-Feared Eylea Sales As Patent Expiration Looms
Investor's Business Daily· 2 days agoRegeneron stock is forming a flat base with a buy point at 998.33, according to MarketSurge. That's...
Earnings call: Pulmonx sees 30% sales boost in Q1, eyes $84M annual target By Investing.com
Investing.com· 2 days agoPulmonx Corporation (ticker: LUNG) reported a robust start to 2024 with a 30% increase in worldwide...
State of New Jersey Common Pension Fund D Buys Shares of 24,044 Viemed Healthcare, Inc. (NASDAQ:VMD)
ETF DAILY NEWS· 2 days agoState of New Jersey Common Pension Fund D purchased a new stake in Viemed Healthcare, Inc. (NASDAQ:VMD – Free Report) in the fourth quarter, Holdings Channel.com ...
Pulmonx Corporation (NASDAQ:LUNG) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 day agoPulmonx Corporation (NASDAQ:LUNG) Q1 2024 Earnings Call Transcript May 1, 2024 Pulmonx Corporation...
Earnings call: Amgen reports robust Q1 2024 sales and pipeline progress By Investing.com
Investing.com· 1 day agoThe biotechnology company has seen a 22% increase in sales, driven by key products such as Repatha,...
